Cardiovascular risk in rheumatoid arthritis patients treated with targeted synthetic and biological disease-modifying antirheumatic drugs: A multi-centre cohort study.

Xinning Tong,Chin-Yao Shen,Ha-Lim Jeon,Yihua Li,Ju-Young Shin, Shirley Cw Chan,Kai Hang Yiu,Nicole L Pratt,Michael Ward,Chak Sing Lau,Ian Ck Wong,Xue Li,Edward Chia-Cheng Lai

JOURNAL OF INTERNAL MEDICINE（2023）

引用 2|浏览0

暂无评分

摘要

There was no difference in the risk of CVE among RA patients initiated with IL-6i, or JAKi compared to TNFi. The finding is consistent in Hong Kong, Taiwan and Korea. This article is protected by copyright. All rights reserved.

查看译文

关键词

bDMARDs,cardiovascular safety of biologics,JAK inhibitors,real-world observational study,rheumatoid arthritis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要